About Us
   Foundry Services
   SIMTech Microfluidics
    Network (SMN)
   Contact Us


2nd April 2014

Swiss-Singapore Workshop on Microfluidics: Innovation and Opportunities was held on Wednesday, 2nd April 2014. The event was jointly organised by the Singapore Institute of Manufacturing Technology (SIMTech), Centre Suisse d’Electronique et de Microtechnique SA (CSEM), Switzerland and swissnex Singapore.

Prominent industry leaders were in attendance to provide critical technological insights with the latest updates on the global Microfluidics industry, as well as to discuss upcoming innovations and future opportunities in the industry.

This workshop also showcased an array of microfluidics technologies, services available, products and competency of SIMTech Microfluidics Foundry for industry to tap on and develop capabilities. Potential collaborations and business opportunities were established through the event.

Please click here for the programme.

12th – 13th Nov 2013

This event was co-organised with Singapore Institute of Manufacturing Technology (SIMTech), a research institute of the Agency for Science and Technology Research (A*STAR), as part of SIMTech's 20th anniversary celebrations. The Conference Chair is Dr. Zhiping Wang, Director of the SIMTech Microfluidics Foundry.

For more information, please check!!

27th - 31st Oct 2013

SMF participated in The 17th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2013) at Freiburg, Germany to meet up with prospective customers and distributors who are interested to learn about what we do here at SMF.

For more information on the event, click here.

12th - 13th Sept 2013

SMF exhibited in the Lab-on-a-Chip World Congress 2013 on 12-13 September in San Diego, at Booth#17.

Town and Country Resort Hotel
500 Hotel Circle North
San Diego, California 92108

For details, please click here.

22nd May 2013

Swiss-Singapore Workshop on Microfluidics 2013

SIMTech, CSEM, Creapole and i-NET in cooperation with swissnex Singapore joined forces to organize a one-day Swiss Singapore workshop on microfluidics. This workshop follows similar successful events of previous years which took place in Singapore and which were organized by swissnex Singapore and the Singapore Institute of Manufacturing Technology (SIMTech). Delegates from Singapore and Switzerland, including some prominent industry leaders, joined the workshop and provided critical technological insights and the latest updates on the global microfluidics industry, as well as the current development in microfluidic applications.

Event venue:
MCH Messe Schweiz (Basel) AG
Congress Center Basel
CH-4005 Basel
Tel: +41 58 206 28 54

Programme at-a-Glance:

6th March 2013

SIMTech Microfluidics Seminar 2013

This seminar was jointly organized by SIMTech and A*STAR Healthcare & Lifestyle (H&L) Programme. Leading scientists were invited to share their cutting-edge research projects and breakthroughs on the latest technological advances and emerging applications related to the microfluidics, or lab-on-a-chip.

Programme at-a-Glance:

For more information, please check here.

16th - 19th December 2012

SMF participated in the 7th Singapore International Chemistry Conference (SICC-7) in conjunction with the 12th Asia-Pacific International Symposium on Microscale Separation and Analysis (APCE 2012), 16th - 19th December 2012 at University Town campus of NUS.

28th Oct – 1st Nov 2012

SMF participated in the µTAS Conference 2012 at Okinawa, Japan on 28th Oct – 1st Nov 2012.

10th - 11th Oct 2012

This event was jointly organised by SIMTech, CSEM Switzerland and Swissnex Singapore. It was targeted at researchers and industry practitioners involved in medical diagnostics, synthesis and drug delivery or others who are active or interested in microfluidics related research and applications, and intend to transfer microfluidics technology from laboratory concepts and prototypes to the market place. Twelve techno-preneurs, from Singapore, Switzerland and the United Kingdom, presented the latest trends, market needs and technologies in microfluidics and new product concepts which are being developed in the pipeline. SIMTech Microfluidics Membership (SMM) was officially launched in conjunction with the event to provide a microfluidics industrialisation platform for start-ups and research groups to excel towards commercialization. SMM certificates were presented to 6 companies: Camtech Management Pte Ltd, CellSievo, Clearbridge BioMedics, JN Medsys, Molbot and QuantuMDx Group UK. Few more partners were signing up the membership right after the event, they are Sparq Wireless Pte. Ltd, Rhodia and Fluigen Pte. Ltd. A total of 205 people attended the first day talks and exhibition. In the second day, the SMM Roundtable discussion (by invitation) was attended by 28 people including invited guests from Switzerland, ETPL (A*STAR) and Spring Singapore.

For event programme, please check here!

25th - 26th Sept 2012


Lab-on-a-Chip World Congress, serious conferences designed to review existing and new life science applications of microfluidic technologies. This year, there were more than 400 registrations and 40 exhibitors in the conference. Most of the attendees are in Lab-on-a-Chip area and it is a relatively small scaled but more interests focused conference. As part of a series of marketing activities planned, this is the 3rd overseas trip after the launch of SIMTech Microfluidics Foundry on 21st September 2011. The main objective of the trip was to promote the SIMTech Microfluidics Foundry and explore business opportunities through the setting up of an exhibition booth at the Lab-on-a-Chip World Congress 2012 held at San Diego, CA. Technology competitive intelligence (TCI) data was gathered at the exhibition and through subsequent university and company visits.

22nd - 24th May 2012

SMF was participating in the Medical Design & Manufacturing (MD&M) East 2012 exposition in Philadelphia on 22nd - 24th May, 2012.

6th Mar 2012

SIMTech Microfluidics Seminar was held on 6th March 2012, Tuesday at SIMTech Auditorium. The seminar had attracted more than 120 executives, managers, engineers, researchers and students from 23 organisations. The topics covered in the seminar included the market opportunities, technology trends, and manufacturing techniques for microfluidics devices. This seminar had provided an excellent forum for interaction and sharing of ideas on the latest technological advances and emerging applications related to the microfluidics, or lab-on-chip.

Six speakers from UK, Korea and Singapore presented in the seminar:

  • “Developing Diagnostics for the Developing World” by Professor Jonathan Cooper, The Wolfson Chair in Bioengineering, Department of Electronics, University of Glasgow, UK.
  • “Manufacturing of Polymer Microfluidics, the Potential and Challenges” by Dr Wang Zhiping, Director of SIMTech Microfluidics Foundry, SIMTech.
  • “Microfluidics from a Commercial Standpoint” by Dr Johnson Ng, Managing Director, JN Medsys Pte Ltd.
  • “Micro Optofluidics and Micro Magnetofluidics, the Emerging Microfluidics Thrusts” by Associate Professor Nguyen Nam-Trung, School of Mechanical and Aerospace Engineering, Nanyang Technology University.
  • “Multiphase Microfluidics for Nanomaterial Synthesis” by Assistant Professor Saif A Khan, Department of Chemical and Biomolecular Engineering, National University of Singapore and.
  • “Rapid Prototyping of Lap-on-a-Chip Devices” by Dr Muntak Son, Chief Technology Officer, Clearbridge Bioloc Pte Ltd.

30th Oct 2011

SIMTech Microfluidics Foundry (SMF) had conducted a launching event in Cambridge, UK on 31st Oct 2011 through its business partner CAMTech Innovations.

Venue of Event: The Howard Building, Downing College, Regent Street, Cambridge. CB2 1DQ
Date: 31st October 2011

The purpose of the launch was to introduce the foundry services to the local academia and companies in UK. These services include research collaborations, design, prototyping and volume production of microfluidics devices. During the launch, SMF had showcased its research and manufacturing capability and sharing some success stories.

SMF had signed an MOU with CAMTech Innovations on 21st September 2011 to promote SMF to potential customers in UK.

21st Sept 2011

The Singapore Institute of Manufacturing Technology (SIMTech), a research institute of the Agency for Science, Technology and Research (A*STAR), launched the SIMTech Microfluidics Foundry (SMF) today. SMF offers an integrated spectrum of capabilities for developing and manufacturing of specialised and low-cost microfluidic devices for applications in healthcare, biomedical, pharmaceutical, energy, water quality monitoring and chemical processing. Reflecting A*STAR’s strategic investments in R&D of innovative high-value manufacturing solutions, this will make Singapore a focal point for public-private sector microfluidic devices investments, R&D and manufacturing.

The Government continues its steadfast investments in growing R&D in Singapore. $16.1 billion Singapore dollars has been earmarked under the Research, Innovation and Enterprise 2011 to 2015 Plan or RIE 2015. This is an overall increase of about 20 per cent over the previous quinquennium and a commitment of 1 per cent of expected Gross Domestic Product (GDP) to public sector research and innovation. With this increased commitment, there is also increased expectation and emphasis on economic impact and fostering commercialisation of R&D. Singapore aims to increase our gross expenditure on R&D (GERD) to 3.5 per cent of GDP by 2015.

The global microfluidics market is estimated to grow to US$5B in 2016 (Yole Developpement 2011, Microfluidic Substrates Market and Processing Trends), driven largely by the advancement of biotechnology and microtechnology. Although Singapore does not presently have a microfluidic industry, Fluidigm and microfluidic start-ups such as CAMTech, Clearbridge Biomedics, JN Medsys, Molbot and Fluigen have set up operations in Singapore for medical/life science applications, seeding the growth of such an industry in Singapore. A key enabling technology that cuts across multiple industry sectors, microfluidics is an important capability that has yet to be exploited.

A*STAR aims to exploit opportunities in the microfluidics space through harnessing our strengths in multi-disciplinary research across the biomedical, physical and engineering sciences. One of the unique and significant value propositions of A*STAR is the spectrum of capabilities that we have and our ability to organise the relevant parts in a synergistic way both within and beyond A*STAR to develop meaningful public-private partnerships.

The microfluidic industry, with its diverse applications spanning from point-of-care, clinical diagnostics, energy, water quality monitoring and chemical processing, is an ideal avenue for diversification and growth for the Singapore precision engineering and electronics industries.

Although microfluidic devices offer rapid analysis and diagnostic functions, the current high manufacturing cost, lack of design and manufacturing standards for large volume manufacturing of microfluidic devices inhibits its widespread commercial adoption. Furthermore, microfluidics with its diverse applications and the distinct requirements for each application make it difficult to standardise for mass production. Currently, many biochips are fabricated using silicon wafers or glass slides. The special processes required during the manufacturing of these silicon-based biochips prove to be expensive for disposable applications. Polymer materials, on the other hand, are better suited for fluidic sample analyses and fabrication can be achieved in bulk at a fraction of the cost for disposable applications. Through its competencies and capabilities to address these challenges, SMF can help nurture and grow the microfluidic industry in Singapore.

SMF provides the emerging microfluidic industry an integrated spectrum of competencies from design, simulation, prototyping to scalable technology development for mass production of polymer-based microfluidic devices. Companies can leverage on the integrated suite of services provided by SMF to reduce cost and improve efficiency as well as translate their laboratory concepts or prototypes to market in the shortest time cost-effectively by accessing the existing competencies and capabilities of microfluidic research in Singapore and Switzerland.

Dr Lim Ser Yong, Executive Director of SIMTech said, "The SIMTech Microfluidics Foundry provides a low-risk environment for companies to place their capital-intensive investments for testing and implementing microfluidic technology solutions. It also offers a strong base for precision engineering and electronics companies to expand and pursue growth in other industries, assisting in the development of microfluidic products for biomedical, pharmaceutical and chemical companies and help start-ups to accelerate its commercialisation process by providing robust manufacturing capabilities and innovative microfluidic solutions."

Today, SIMTech signed three research agreements with Rhodia Asia Pacific, CAMTech Management and Molbot to develop high-throughput microfluidic tools for applications and product development in pharmaceuticals; for water quality monitoring and for gene cloning respectively. SIMTech also signed a Memorandum of Understanding with CAMTech Innovations (UK) and Clearbridge Biomedics to jointly develop design and manufacturing technologies of microfluidic devices for life science companies as well as intends to collaborate on development of manufacturing technologies and solutions for microfluidic devices for potential commercial use respectively. These microfluidic R&D commitments reflect the confidence of industry in SMF’s competencies and capabilities, seeding a growing microfluidic industry in Singapore.

Dr Mario El-Khoury, CSEM Chief Executive Officer, said: "The SIMTech Microfluidics Foundry is a successful outcome of the research collaboration between CSEM and SIMTech. Today, SMF is a milestone for Singapore to grow the microfluidic industry. We look forward to furthering our collaboration with SMF to advance the microfluidic technology and its applications that impact the quality of life, such as healthcare, biomedical and life science research."

To download press release, click here

21st Sept 2011

Microfluidics is an emerging technology which leverages on the miniaturisation of fluid handling system to enable precise control and manipulation of small fluid volumes for various applications, such as point-of-care and clinical diagnostics, pharmaceutical and life science research, analytical and monitoring devices, and drug delivery.

The SIMTech Microfluidics Foundry (SMF) is established by the Singapore Institute of Manufacturing Technology (SIMTech), a research institute of the Agency for Science, Technology and Research (A*STAR), to advance the microfluidic technology as well as nurture and grow microfluidics industry in Singapore by providing the infrastructure support and manufacturing solutions to the academic and industrial community.

The theme of the workshop is Microfluidics: From Laboratories To Market. Speakers from Singapore and Switzerland including Dr Mario El-Khoury, CEO of CSEM, and other prominent industry leaders will provide critical technological insights, the latest update on the global microfluidics industry and the current development in microfluidic applications. Dr Frédéric Breussin, Project Manager of Yole Développement, France, the leading marketing and technology consultancy company in microfluidics, will also present a keynote speech on the Markets and Technology Trends for Microfluidic Applications.

There will also be product and research showcase to demonstrate SIMTech capabilities and technologies for the microfluidics industry, including microfluidic devices and systems developed for various applications.

Microfluidics is a new industry platform for the Singapore precision engineering and electronics companies to diversify into the medical and medtech industries. Learn about this new opportunity for growth for your company.

For a copy of the programme, please click here.

Admission to this event is complimentary. Pre-registration is required and on a first-come, first served basis.

For enquiries,
Email: smf@SIMTech.a-star.edu.sg
Telephone: +65 6793 8383

5th - 7th Jan 2011

The second conference on Advances in Microfluidics and Nanofluidics, and Asian-Pacific International Symposium on Lab on Chip (AMN-APLOC), jointly organised by SIMTech and Nanyang Technological University (NTU), at Biopolis Singapore is happening on 5th - 7th January 2011. It is a joint conference on Advances in Microfluidics and Nanofluidics and Asian-Pacific International Symposium on Lab on Chip.

AMN - APLOC 2011 attendees are from diverse fields in engineering, physics, chemistry, biology, life science as well as microtechnology and biotechnology.  AMN - APLOC 2011 will provide a highly interactive forum to bring together researchers of different disciplines, from academia & research institutions, industry and public organisations with the aim of acquiring, exchanging and promoting the knowledge and new advances on microfluidics & nanofluidics and Lab-on Chip sciences, technologies and applications.

The invited speakers are leading microfluidics & nanofluidics and Lab-on-Chip world-known researchers in Physics, Chemistry and the various engineering disciplines.

Click here for the conference website.

26th Aug 2009

The Singapore Institute of Manufacturing Technology (SIMTech), a research institute of the Agency for Science, Technology and Research (A*STAR), announced the signing of a Memorandum of Understanding with the Centre Suisse d’Electronique et de Microtechnique SA (CSEM), Switzerland, to carry out joint research projects and facilitate the exchange of research and scientific staff members to advance the development of microfluidics technology.

Microfluidics technology has been adopted for increasingly diverse use in ink-jet printing, lab-on-a-chip, biomedical research and diagnostics, chemical processing, water monitoring and the harnessing of alternative energy. According to Yole Development (EMMA2007), the potential market size of microfluidics technology in life science alone will be about US$2 billion in 2012. Advances in microfluidics technology are well aligned with Singapore’s long-term R&D thrusts to grow the strategic clean energy, water, environment and biomedical industries.

The three-year collaboration between the institutes of the two countries will build upon the collective and complementary research capabilities in microfluidics technology and microsystem technology of SIMTech and CSEM, respectively. The proposed research collaboration areas will cover microsystem technology, environmental monitoring, microfluidics and lab-on-a-chip developments.

“The multi-disciplinary joint collaboration drawing on the strengths of both institutes will accelerate the advancement of microfluidics technology. The accelerated development will enable the clean energy, environment, water and biomedical industries to leverage on the outcomes and achievements for a clear competitive advantage. More importantly, the joint multi-disciplinary microfluidics development offers the industry microfluidics solutions in an integrated platform“ commented Dr Lim Ser Yong, Executive Director, SIMTech.

“SIMTech and CSEM have already worked together for a long time, and it is a great pleasure for us to intensify this collaboration in a field of high strategic value and high commercial interest, especially for all issues concerning microsystems technologies. CSEM and SIMTech together will be able to push the boundaries of the technology in this area, ” said Prof Thomas Hinderling, CEO, CSEM.



Copyright © 2011. Singapore Institute of Manufacturing Technology